June Almenoff - Insider Trading & Ownership

Entity: Individual
Location: C/O Brainstorm Cell Therapeutics Inc., 1325 Avenue Of Americas 28 Th Floor, New York, NY
Summary: The estimated net worth of June Almenoff is at least $112K dollars as of April 2, 2025. June Almenoff is the Director of Avalo Therapeutics, Inc. and owns shares of Avalo Therapeutics, Inc. (AVTX) stock worth about $88.8K. June Almenoff is the Director of BRAINSTORM CELL THERAPEUTICS INC. and owns shares of BRAINSTORM CELL THERAPEUTICS INC. (BCLI) stock worth about $23.4K.
All Insider Reports: All Insider Reports

Ownership of June Almenoff

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
AVTX	Avalo Therapeutics, Inc.	Director	$88.8K	+$12.8K	+16.8%	Mar 28, 2025
BCLI	BRAINSTORM CELL THERAPEUTICS INC.	Director	$23.4K			Dec 15, 2021
ATNM	Actinium Pharmaceuticals, Inc.	Director				Mar 31, 2025
TENX	TENAX THERAPEUTICS, INC.	Director				Dec 10, 2024

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.